From our practice

Notes

Eucade’s own analysis of what wins, across all three routes. No client cases, no invented figures.

Open callsDigital & Cyber

On the rise of cyber cascade

Why regulation, not hype, is driving cybersecurity cascade funding, and what that means for how you write.

Read note
Open callsAI, Data & Smart Industry

Evidence beats novelty

In sectoral-AI calls, the panel has stopped believing "state of the art." Here is what it rewards instead.

Read note
Open callsCleanTech

Impact in the evaluators' language

The most common reason strong clean-tech applications lose points on impact, and the fix.

Read note
Open callsAcross sectors

Why applications fail before the technology is read

Two administrative things decide a cascade application before its technical merit is weighed. Both are inside your control.

Read note
Open callsHealth & Life Sciences

Two health calls that everyone calls a grant, and neither is

EIT Health takes options over your equity before a single euro moves. Almost every summary of these calls leaves that out.

Read note
Joint R&D TrackJoint transnational R&D

Eligibility decides before the science is read

Eurostars rejects on seven administrative criteria before an assessor reaches your technology. Four of them catch people who deserved to pass.

Read note
Scale-up TrackDeeptech scale-up

The EIC decides in two places, and most preparation ignores the first

Roughly one in eight full applications reaches the interview. About half of those that do are funded. That asymmetry should decide how you prepare.

Read note